Circulating Biomarkers to Identify Responders in Cardiac Cell therapy

Bone marrow mononuclear cell (BM-MNC) therapy in ST-elevation acute myocardial infarction (STEMI) has no biological inclusion criteria. Here, we analyzed 63 biomarkers and cytokines in baseline plasma samples from 77 STEMI patients treated with BM-MNCs in the TIME and Late-TIME trials as well as 61...

Descripción completa

Detalles Bibliográficos
Autores principales: Jokerst, Jesse V., Cauwenberghs, Nicholas, Kuznetsova, Tatiana, Haddad, Francois, Sweeney, Timothy, Hou, Jiayi, Rosenberg-Hasson, Yael, Zhao, Eric, Schutt, Robert, Bolli, Roberto, Traverse, Jay H., Pepine, Carl J., Henry, Timothy D., Schulman, Ivonne H., Moyé, Lem, Taylor, Doris A., Yang, Phillip C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493650/
https://www.ncbi.nlm.nih.gov/pubmed/28667255
http://dx.doi.org/10.1038/s41598-017-04801-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493650/
https://www.ncbi.nlm.nih.gov/pubmed/28667255
http://dx.doi.org/10.1038/s41598-017-04801-7

Ejemplares similares